Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Management of Multiple Sclerosis in the Breastfeeding Mother.
[Multiple sclerosis (2) - Round table: Upper limb and balance.]
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Multiple sclerosis: Genotyping study identifies a plethora of new susceptibility variants for multiple sclerosis.
Clinical and Magnetic Resonance Imaging (MRI) Distinctions Between Tumefactive Demyelination and Brain Tumors in Children.
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
Neurology issues in schizophrenia.
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.
Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints.
The human oligodendrocyte proteome.
Assessing risks of multiple sclerosis therapies.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Effect of passive whole-body heating on central conduction and cortical excitability in multiple sclerosis patients and healthy controls.
Do We Need Worms to Promote Immune Health?
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.
The use of immune modulating drugs for the treatment of multiple sclerosis.
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Circulating CD56(dim) NK cells expressing perforin are increased in progressive multiple sclerosis.
Antivirus immune activity in multiple sclerosis correlates with MRI activity.
Sexual problems among women with multiple sclerosis.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
Internal jugular and vertebral vein volume flow in patients with clinically isolated syndrome or mild multiple sclerosis and healthy controls: results from a prospective sonographer-blinded study.
Menopause in multiple sclerosis: therapeutic considerations.

Pages